VERO

Venus Concept Inc

NASDAQ

Add Alert

VERO

Venus Concept Inc

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Monksdream PremiumMember

03/15/24 1:32 PM

Post #48

Re: #46: @Awl416 - Venus Concept Announces CE Mark for Venus Versa

VERO new 52 week lo

Invest-in-America PremiumMember

02/22/24 7:55 AM

Post #47

VERO: Cute nomenclature for a routine to fix flucked-up Human SKIN!!! ("VENUS"; heck, in the EU now they can call it "VENUS DE MILO!!")

Awl416

02/22/24 7:50 AM

Post #46

Venus Concept Announces CE Mark for Venus Versa Pro in Europe

Triple nickle Free

05/09/23 3:50 PM

Post #45

Building up steam

Triple nickle Free

05/09/23 11:10 AM

Post #44

It went positive yesterday

Triple nickle Free

05/09/23 11:06 AM

Post #43

Buy rating to 2.20

Triple nickle Free

05/09/23 11:05 AM

Post #42

Adding

81vette

12/22/22 11:24 AM

Post #41

finally, accumulation started,seller/debt might be done,its moving better now

81vette

12/21/22 7:01 PM

Post #40

Shares outstanding 67m,volume today 78m,lots of bills paid today,future looking good with many other news worthy products in pipeline

81vette

12/21/22 3:49 PM

Post #39

$29.5m traded today(record high),follow the money,monthly trend so far

81vette

12/21/22 3:24 PM

Post #38

gap filled,rsi bouncing off oversold,loading zone now

81vette

12/21/22 1:22 PM

Post #37

300Xs ave volume,at least 10x pps should follow

Bullish

81vette

12/21/22 10:55 AM

Post #36

zero borrow,no shares to short>12.83% 0.00% 0 2022-12-21 10:45:03
12.83% 0.00% 0 2022-12-21 10:30:03
12.83% 0.00% 0 2022-12-21 10:15:03
12.83% 0.00% 0 2022-12-21 10:00:03
12.83% 0.00% 0 2022-12-21 09:45:03
12.83% 0.00% 0 2022-12-21 09:30:03
12.83% 0.00% 0 2022-12-21 09:15:04
12.83% 0.00% 0 2022-12-21 09:00:03
12.83% 0.00% 0 2022-12-21 08:45:04
12.83% 0.00% 0 2022-12-21 08:30:03
12.83% 0.00% 0 2022-12-21 08:15:03
12.83% -8.51% 75000 2022-12-21 08:00:03
12.83% -8.51% 850000 2022-12-20 17:45:03
12.83% -8.51% 850000 2022-12-20 17:30:04
12.83% -8.51% 850000 2022-12-20 17:15:03
12.83% -8.51% 850000 2022-12-20 17:00:04
12.83% -8.51% 850000 2022-12-20 16:45:04

81vette

12/21/22 10:15 AM

Post #35

FDA news this big should run many days

Bullish

subslover

12/21/22 8:20 AM

Post #34

Re: #33: @reena969 - ..64 = 100%

Venus Concept Receives 510(k) Clearance for Use of its AI.ME™ Next Generation Robotic Technology for Fractional Skin Resurfacing
December 21 2022 - 07:00AM
GlobeNewswire Inc.
Alert
Print
Share On Facebook

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its AI.ME next generation robotic technology for fractional skin resurfacing.

“We are very pleased to receive the first FDA regulatory clearance for our non-surgical robotic technology platform, AI.ME, and believe it showcases Venus Concept’s ongoing investment in technology, innovation, and clinical research towards robotics applications in the field of medical aesthetics,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “AI.ME is a first-of-its-kind robotic platform offering physicians minimally-invasive treatments for high-demand procedures requiring fractional skin resurfacing. We see AI.ME as a versatile platform and we will continue to develop the platform to provide innovative solutions in various areas of medical aesthetics, starting with fractional skin resurfacing. The AI.ME technology will be critical to maximizing the synergy between our well-established medical aesthetic business and our pioneering robotics business driven by a robust R&D pipeline developed by our team in San Jose. This 510(k) clearance brings us one step closer to our goal of commercializing AI.ME in the U.S., and we look forward to introducing our first AI.ME systems with Venus Concept’s leading physician partners in 2023.”

The AI.ME robotic system utilizes an advanced visualization system, machine vision, and Artificial Intelligence algorithms to target the dermis in a pre-planned selective, and predictable manner. It uses a smart array of micro-coring hollow punches to precisely core and excise micro-skin fractions at a precise depth to remove up to 10% of skin in the treatment area, leading to collagen deposition and fractional skin resurfacing of the treated area.

“Integrating the advancements of robotics into the area of minimally-invasive aesthetic procedures is very promising,” said Girish (Gilly) Munavalli, MD, MHS, FACMS board-certified dermatologist and advisor to Venus Concept. “This new technology may become a real game-changer in the area of medical aesthetics, offering a new level of consistency, predictability, and visualization which will differentiate it from existing energy-based solutions. We had the privilege to participate in the early clinical studies of AI.ME and it is clear that the advancements that its robotic technology presents to our practice can go far beyond fractional skin resurfacing. I’m encouraged to see some true innovation in the area of minimally-invasive aesthetic treatments and I’m looking forward to seeing the technology evolve to produce consistent transformational results.”

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 16 direct markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept’s hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.

Cautionary Statement Regarding Forward-Looking Statements

reena969

12/21/22 8:18 AM

Post #33

..64 = 100%

reena969

12/21/22 8:17 AM

Post #32

FDA news $$$

DK11

11/28/22 10:13 PM

Post #31

I thought this stock was about to show promise, maybe not

DK11

11/28/22 5:46 PM

Post #30

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001409269/000143774922026907/vero20220930_10q.htm
Is this stock going to be de-listed from Nasdaq read page 58.???

DK11

11/28/22 1:35 PM

Post #29

This is super tight it has to go. Ready to explode

INFINITI

11/21/22 9:32 AM

Post #28

Super thin here$$$

INFINITI

11/20/22 1:44 PM

Post #27

Should be an awsome week $$$$

INFINITI

11/18/22 10:11 AM

Post #26

Looking good here I’m in $$$$$

Zardiw

09/05/22 9:52 AM

Post #25

Re: #21: @makinezmoney - $VERO: My bad...... $25.8MIlly in QUARTERLY REVS

#DDAmanda Chart on: $VERO :

You can scan for these before they run.

#DDAmanda is still the best way to find #WinningStocks before they run.
Contact/Text: 760 702-2009

What the Fact (Factor) Column is:

The Factor is a proprietary indicator used for scanning in #DDAmanda.

It's defined as Today's $Traded divided by the average daily $Traded (20 day avg).

SO, if a stock has say a 10 Factor that day, it means she traded 10 Times the $ she normally trades.

That's significant, and many times indicates that a run in the stock is coming.

lecorb

08/13/21 2:51 PM

Post #24

Re: #23: @lecorb - Venus Concept Stock Trades Higher After Lifting FY21

First rating to update target price today!
Marie Thibault
BTIG
4.5 Stars
target
$7.00
ranking
Buy
analystAction
Reiterated
date
14 hours ago
TDAmeritrade Inc.

lecorb

08/13/21 11:31 AM

Post #23

Re: #21: @makinezmoney - $VERO: My bad...... $25.8MIlly in QUARTERLY REVS

Venus Concept Stock Trades Higher After Lifting FY21 Sales Outlook
11:19 am ET August 13, 2021 (Benzinga) Print
Venus Concept Inc's (NASDAQ: VERO) Q2 sales increased 52% Y/Y to $25.8 million, beating the consensus of $24.26 million.
The increase by product category was driven by a 71% increase in lease revenue, a 29% increase in systems revenue, an 86% increase in products revenue, and a 5% increase in services revenue.
The gross margin improved to 72.5% from 70.0%, primarily driven by higher sales of Venus consumables and improved revenue mix of system sales sold under our subscription program, tracing to Venus Bliss.
Operating income increased 117% Y/Y to $1.5 million compared to a loss of $(8.8) million a year ago.
EPS of $0.01 improved from a loss of $(0.39) and ahead of analyst estimate loss of $(0.12).
FY21 Guidance: Venus expects sales of $102 million - $107 million, representing a 31% - 37% Y/Y increase, better than the Wall Street estimate of $103.24 million.
Prior sales estimate were $100 million - $105 million, +28% to 35%, Y/Y.
Price Action: VERO shares are up 1.91% at $2.13 during the market session on the last check Friday.

lecorb

08/13/21 11:22 AM

Post #22

Re: #21: @makinezmoney - $VERO: My bad...... $25.8MIlly in QUARTERLY REVS

NSTITUTIONAL OWNERSHIP CHANGES (13F FILINGS) FOR VENUS CONCEPT (NASDAQ:VERO)
Institutional Ownership Percentage: 43.04%

8/13/2021 Vanguard Group Inc. 1,011,657 $3.15M 0.0% +3.4% 1.871%
8/12/2021 Dimensional Fund Advisors LP 116,052 $0.36M 0.0% +29.8% 0.215%
8/12/2021 Essex Investment Management Co. LLC 733,425 $2.28M 0.3% +47.2% 1.356%
8/12/2021 Ergoteles LLC 107,516 $0.33M 0.0% N/A 0.199%
8/11/2021 Bank of New York Mellon Corp 36,048 $0.11M 0.0% -57.4% 0.067%
8/11/2021 Deutsche Bank AG 59,500 $0.19M 0.0% +396.7% 0.110%
8/11/2021 Susquehanna Fundamental Investments LLC 13,000 $40K 0.0% N/A 0.024%
8/3/2021 Oppenheimer & Co. Inc. 15,500 $48K 0.0% N/A 0.029%

makinezmoney Free

08/13/21 11:17 AM

Post #21

Re: #20: @lecorb - When they double their target price, possibly the

$VERO: My bad...... $25.8MIlly in QUARTERLY REVS

And Venus Williams ?????????

WOW

Cheap here at $2.10 now

Confidence is Venus Williams' secret to looking and feeling her best. In this master video, watch as Venus explains all the reasons why she loves Venus Bliss™! https://t.co/37CHKiwSDd
— Venus Aesthetic Intelligence (@Venus_A_I) August 3, 2021

GO $VERO

lecorb

08/13/21 11:14 AM

Post #20

Re: #19: @makinezmoney - $VERO: Solid Earnings report......... $2.58Milly quarterly revs

When they double their target price, possibly the monday more than one compulsive short seller will cry a lot

Marie Thibault
BTIG
StarStarStarStarStar
target
$7.00
ranking
Buy
analystAction
Reiterated
date
2 months ago

Anthony Vendetti
Maxim Group
StarStarStarStarStar
target
$6.00
ranking
Buy
analystAction
Reiterated
date
3 months ago

Suraj Kalia
Oppenheimer
StarStarStarStarStar
target
$4.00
ranking
Buy
analystAction
Maintained
date
3 months ago

makinezmoney Free

08/13/21 7:42 AM

Post #19

$VERO: Solid Earnings report......... $2.58Milly quarterly revs

BRIEF-Venus Concept Announces Second Quarter 2021 Financial Results Increases Fiscal Year 2021 Revenue Guidance
7:14 AM ET 8/13/21 | Reuters
BRIEF-Venus Concept Announces Second Quarter 2021 Financial Results Increases Fiscal Year 2021 Revenue Guidance
Aug 13 (Reuters) - Venus Concept Inc:

* VENUS CONCEPT ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS; INCREASES FISCAL YEAR 2021 REVENUE GUIDANCE

* Q2 REVENUE $25.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $24.3 MILLION

* SEES FY 2021 REVENUE UP ABOUT 31 TO 37 PERCENT

* SEES FY 2021 REVENUE $102 MILLION TO $107 MILLION

* FY2021 REVENUE VIEW $103.2 MILLION -- REFINITIV IBES DATA

* Q2 EARNINGS PER SHARE $0.01

* Q2 EARNINGS PER SHARE VIEW $-0.12 -- REFINITIV IBES DATA Source text for Eikon: Further company coverage:

GO $VERO

OR Nurse

12/21/20 6:43 PM

Post #18

Re: #10: @CRNA - Isn’t anybody excited about zaring. Scoping out the

CRNA. You don't think you can sneak into VERO headquarters and snap a few photos and see if you see anything can you? Perhaps post them here. Asking for a friend. lol

OR Nurse

12/21/20 6:43 PM

Post #17

Re: #10: @CRNA - Isn’t anybody excited about zaring. Scoping out the

CRNA. You don't think you can sneak into VERO headquarters and snap a few photos and see if you see anything can you? Perhaps post them here. Asking for a friend.

Adrock

12/18/20 7:54 PM

Post #16

Re: #15: @BigT82 - Growing BIG after hours pal! To da mooooon!!

HAIR OUT THE ENOS pal!!

BigT82

12/18/20 7:52 PM

Post #15

Re: #14: @Adrock - SCOOOOOOOOOOOOP DAT HAIR GROWTH!

Growing BIG after hours pal!

To da mooooon!!

Adrock

12/18/20 6:56 PM

Post #14

Re: #13: @BigT82 - Nice pop! Let’s goooo! Huge Monday news coming! Merger Monday!?

SCOOOOOOOOOOOOP DAT HAIR GROWTH!

BigT82

12/18/20 6:42 PM

Post #13

Nice pop! Let’s goooo!

Huge Monday news coming!

Merger Monday!?

Adrock

12/02/20 6:57 AM

Post #12

Re: #11: @BigT82 - Moving on up! Let’s gooo!

Scooooooooooooooop Em!!!

BigT82

12/01/20 1:50 PM

Post #11

Moving on up! Let’s gooo!

CRNA

08/03/20 2:46 PM

Post #10

Isn’t anybody excited about zaring. Scoping out the company for Medtronic for a buyout

Roadtojourney Free

07/02/20 9:47 AM

Post #9

Re: #8: @Roadtojourney - This was higher few days back even before

Ofcouse imo

Roadtojourney Free

07/02/20 9:46 AM

Post #8

This was higher few days back even before this fluff news

Roadtojourney Free

07/02/20 9:42 AM

Post #7

Re: #6: @saigai - volume is awesome...

Makes no sense volume was more yesterday AH

saigai

07/02/20 9:38 AM

Post #6

Re: #5: @Roadtojourney - Why is it not flying?? The news is

volume is awesome...

Roadtojourney Free

07/02/20 8:44 AM

Post #5

Why is it not flying?? The news is good the stock is good too??

Roadtojourney Free

07/01/20 4:43 PM

Post #4

And down it goes

boston127

01/14/20 10:21 AM

Post #3

Starts out slow every AM.

I have noticed this trend. Thus, I pick up an additional 100-200 shares in the AM and do not get flustered with momentary ups and downs. The trend is our friend.

boston127

01/13/20 6:11 PM

Post #2

Venus Concept started at outperform

with $15 stock price target at Oppenheimer (1-10-2020). They are a very credible investment firm. Think I will hang in here for awhile.

boston127

01/13/20 10:25 AM

Post #1

Nice move up today.

I doubled up my holdings this AM, just as it hit the high of the day. ): That's OK. This is a keeper. The products are great.

Fiscal Year 2020 Revenue Guidance:

Total revenue for the twelve months ended December 31, 2020 is expected to be in the range of $134.0 million to $140.0 million. The Company’s fiscal year 2020 revenue guidance range represents projected growth of approximately 9% to 13% year-over-year as compared to the preliminary total revenue range, on a pro-forma basis, of $122.6 million to $123.5 million for the twelve months ended December 31, 2019.

Venus Concept Inc (VERO)

Followers	4	Posters	19
Posts (Today)	0	Posts (Total)	48
Created	01/13/20	Type	Free
Moderators

Venus Concept started at outperform with $15 stock price target at Oppenheimer

8:53 am ET January 10, 2020 (MarketWatch

Venus Concep, Inc., formerly Restoration Robotics, Inc., develops and manufactures devices for the medical aesthetic market. The Company offers a range of products and services under various brands, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Heal, Venus Skin and Venus Bliss. It offers a product portfolio of minimally invasive and non-invasive medical aesthetic technologies in over 60 countries and 29 direct markets. Its hair restoration division includes NeoGraft, an automated hair restoration system that facilitates the harvesting of follicles during a follicular unit extraction (FUE) process. Venus Viva includes NanoFractional Radio Frequency (RF) and SmartScan technology. It offers aesthetic products for the treatment of face, neck and body. Venus Fiore is designed with three applicators to address internal vaginal health restoration, labia skin tightening and mons pubis reduction.
https://www.venusconcept.com/en-us/

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic technologies, and reach in over 60 countries and 29 direct markets. Venus Concept focuses its product sale strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa™, Venus Legacy™, Venus Velocity™, Venus Fiore™, Venus Viva™, Venus Freeze Plus™, and Venus Bliss™. Venus Concept’s hair restoration division includes NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX™ Robotic Hair Restoration Systems, which harvests follicular units directly from the scalp and create recipient implant sites using proprietary algorithms.

Venus Freeze Plus™ is the easiest-to-use system with advanced safety features for non-invasive skin tightening* and wrinkle reduction. It features two applicators: DiamondPolar™ for smaller treatment areas and OctiPolar™ for larger areas. Both of these lightweight, ergonomically designed applicators are powered by our proprietary (MP)² technology, combining Multi-Polar Radio Frequency and Pulsed Electro Magnetic Fields. Treatments are extremely comfortable with no downtime for patients and safe for all skin types. Venus Freeze Plus™ is the ideal system for anyone looking to break into the medical aesthetic industry. in the industry. In partnering with Venus Concept, aesthetic professionals worldwide gain access to never-before-seen business features such as the most comprehensive warranty program, unmatched marketing support, continuous clinical education, valuable practice enhancement programs, and more—all at no additional cost.

© Copyright 2019 Venus Concept. All rights reserved. Venus Freeze Plus™, Venus Viva™, Venus Legacy™, Venus Velocity™ and Venus Versa™ are trademarks of Venus Concept™ and may be registered in certain jurisdictions.